These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

131 related items for PubMed ID: 7907854

  • 1. Expression of HER-2/neu oncoprotein and epidermal growth factor receptor and prognosis in gastric carcinoma.
    Lee EY, Cibull ML, Strodel WE, Haley JV.
    Arch Pathol Lab Med; 1994 Mar; 118(3):235-9. PubMed ID: 7907854
    [Abstract] [Full Text] [Related]

  • 2. Intracellular coexpression of epidermal growth factor receptor, Her-2/neu, and p21ras in human breast cancers: evidence for the existence of distinctive patterns of genetic evolution that are common to tumors from different patients.
    Shackney SE, Pollice AA, Smith CA, Janocko LE, Sweeney L, Brown KA, Singh SG, Gu L, Yakulis R, Lucke JF.
    Clin Cancer Res; 1998 Apr; 4(4):913-28. PubMed ID: 9563885
    [Abstract] [Full Text] [Related]

  • 3. Expression of EGFR, HER-2/neu, P53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas.
    Khalifa MA, Mannel RS, Haraway SD, Walker J, Min KW.
    Gynecol Oncol; 1994 Apr; 53(1):84-92. PubMed ID: 7909788
    [Abstract] [Full Text] [Related]

  • 4. Expression of receptor tyrosine kinases epidermal growth factor receptor and HER-2/neu in synovial sarcoma.
    Thomas DG, Giordano TJ, Sanders D, Biermann S, Sondak VK, Trent JC, Yu D, Pollock RE, Baker L.
    Cancer; 2005 Feb 15; 103(4):830-8. PubMed ID: 15641030
    [Abstract] [Full Text] [Related]

  • 5. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF, Pike MC, Chazin VR, Hung G, Udove JA, Markowicz M, Danyluk J, Godolphin W, Sliwkowski M, Akita R.
    Cancer Res; 1993 Oct 15; 53(20):4960-70. PubMed ID: 8104689
    [Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor receptor and c-erbB-2 oncoprotein expression in female genital tract carcinosarcomas (malignant mixed müllerian tumors). Clinicopathologic study of 82 cases.
    Costa MJ, Walls J.
    Cancer; 1996 Feb 01; 77(3):533-42. PubMed ID: 8630962
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HER-2/neu oncogene expression and proliferation in breast cancers.
    Bacus SS, Ruby SG, Weinberg DS, Chin D, Ortiz R, Bacus JW.
    Am J Pathol; 1990 Jul 01; 137(1):103-11. PubMed ID: 1973597
    [Abstract] [Full Text] [Related]

  • 9. Characterization of the HER-2/neu oncogene by immunohistochemical and fluorescence in situ hybridization analysis in oral and oropharyngeal squamous cell carcinoma.
    Khan AJ, King BL, Smith BD, Smith GL, DiGiovanna MP, Carter D, Haffty BG.
    Clin Cancer Res; 2002 Feb 01; 8(2):540-8. PubMed ID: 11839675
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical study of HER-2/neu, epidermal growth factor receptor, and steroid receptor expression in normal and malignant endometrium.
    Bigsby RM, Li AX, Bomalaski J, Stehman FB, Look KY, Sutton GP.
    Obstet Gynecol; 1992 Jan 01; 79(1):95-100. PubMed ID: 1345772
    [Abstract] [Full Text] [Related]

  • 11. Gastric carcinoma: expression of c-erbB-2/neu oncoprotein, epidermal growth factor receptor, cathepsin D, progesterone receptor and tumor associated glycoprotein-72 in different histological types.
    Peláez Buján Mdel C, Ruibal Morell A, Aza González J.
    Rev Esp Enferm Dig; 1999 Dec 01; 91(12):826-37. PubMed ID: 10619912
    [Abstract] [Full Text] [Related]

  • 12. Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
    Massard C, Voigt JJ, Laplanche A, Culine S, Lortholary A, Bugat R, Theodore C, Priou F, Kaminsky MC, Lesimple T, Pivot X, Coudert B, Douillard JY, Merrouche Y, Fizazi K.
    Br J Cancer; 2007 Oct 08; 97(7):857-61. PubMed ID: 17876336
    [Abstract] [Full Text] [Related]

  • 13. High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.
    Yi ES, Harclerode D, Gondo M, Stephenson M, Brown RW, Younes M, Cagle PT.
    Mod Pathol; 1997 Feb 08; 10(2):142-8. PubMed ID: 9127320
    [Abstract] [Full Text] [Related]

  • 14. Expression of the epidermal growth factor receptor and Her-2 are predictors of favorable outcome and reduced complete response rates, respectively, in patients with muscle-invading bladder cancers treated by concurrent radiation and cisplatin-based chemotherapy: a report from the Radiation Therapy Oncology Group.
    Chakravarti A, Winter K, Wu CL, Kaufman D, Hammond E, Parliament M, Tester W, Hagan M, Grignon D, Heney N, Pollack A, Sandler H, Shipley W.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):309-17. PubMed ID: 15890569
    [Abstract] [Full Text] [Related]

  • 15. Expression of epidermal growth factor receptor and ERBB2 (HER-2/Neu) oncoprotein in prostatic carcinomas.
    Visakorpi T, Kallioniemi OP, Koivula T, Harvey J, Isola J.
    Mod Pathol; 1992 Nov 01; 5(6):643-8. PubMed ID: 1369801
    [Abstract] [Full Text] [Related]

  • 16. Expression of epidermal growth factor receptor family proteins (EGFR, c-erbB-2 and c-erbB-3) in gastric cancer and chronic gastritis.
    Slesak B, Harlozinska A, Porebska I, Bojarowski T, Lapinska J, Rzeszutko M, Wojnar A.
    Anticancer Res; 1998 Nov 01; 18(4A):2727-32. PubMed ID: 9703936
    [Abstract] [Full Text] [Related]

  • 17. HER-2 expression and response to tamoxifen in estrogen receptor-positive breast cancer: a Southwest Oncology Group Study.
    Elledge RM, Green S, Ciocca D, Pugh R, Allred DC, Clark GM, Hill J, Ravdin P, O'Sullivan J, Martino S, Osborne CK.
    Clin Cancer Res; 1998 Jan 01; 4(1):7-12. PubMed ID: 9516946
    [Abstract] [Full Text] [Related]

  • 18. The expression of epidermal growth factor receptor and transforming growth factor alpha in renal cell carcinoma.
    Lager DJ, Slagel DD, Palechek PL.
    Mod Pathol; 1994 Jun 01; 7(5):544-8. PubMed ID: 7937720
    [Abstract] [Full Text] [Related]

  • 19. [Association of HER-2/neu expression with prognosis of gastric cancer].
    Chen B, Luo RC, Cui F, Qian XY.
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar 01; 26(3):344-7. PubMed ID: 16546744
    [Abstract] [Full Text] [Related]

  • 20. EGFR activity in HER-2 over-expressing metastatic breast cancer: evidence for simultaneous phosphorylation of Her-2/neu and EGFR.
    Gschwantler-Kaulich D, Hudelist G, Koestler WJ, Czerwenka K, Mueller R, Helmy S, Ruecklinger E, Kubista E, Singer CF.
    Oncol Rep; 2005 Aug 01; 14(2):305-11. PubMed ID: 16012707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.